Literature DB >> 22941167

BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.

Martha A Zeiger, Eric B Schneider.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22941167     DOI: 10.1245/s10434-012-2614-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  The Prediction of Sonographic features and BRAF Mutation for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Reply.

Authors:  Ning Qu; Rong-liang Shi; Ben Ma; Yi Gao; Yu Wang; Qing-hai Ji
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

2.  The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis.

Authors:  Daniele Barbaro; Roberto Mario Incensati; Gabriele Materazzi; Giuseppe Boni; Mariano Grosso; Erica Panicucci; Paola Lapi; Cristina Pasquini; Paolo Miccoli
Journal:  Endocrine       Date:  2013-08-08       Impact factor: 3.633

3.  BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma.

Authors:  Lauren E Henke; John D Pfeifer; Changquing Ma; Stephanie M Perkins; Todd DeWees; Samir El-Mofty; Jeffrey F Moley; Brian Nussenbaum; Bruce H Haughey; Thomas J Baranski; Julie K Schwarz; Perry W Grigsby
Journal:  Cancer Med       Date:  2015-02-25       Impact factor: 4.452

4.  Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.

Authors:  Ruoting Lin; Conor E Fogarty; Bowei Ma; Hejie Li; Guoying Ni; Xiaosong Liu; Jianwei Yuan; Tianfang Wang
Journal:  BMC Genomics       Date:  2021-07-27       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.